Joel Wight

9PUBLICATIONS
53CO-AUTHORS
Language documentation and descriptionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursRespiratory diseasesOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 07, 2026
Australasian chronic lymphocytic leukaemia consensus statement: 2026 update.

|Nov 24, 2025
Effective management of daratumumab-induced cytopenias with hematopoietic stem cell infusion in relapsed/refractory multiple myeloma: a case report.

Olivia Slogrove, Joel Wight

|Jul 27, 2025
Real-world utilization of Bruton tyrosine kinase inhibitors in relapsed/refractory chronic lymphocytic leukemia in Australia.

Stephen P Mulligan, Philip A Thompson, Joel Wight

|Aug 19, 2024
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance.

Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur

|Mar 11, 2023
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study.

Kate Manos, Geoffrey Chong, Colm Keane

|May 16, 2022
Toxicity associated with high-dose intravenous methotrexate for hematological malignancies.

Joel Wight, Matthew Ku, Melissa Garwood

Pageof 2

Frequent Collaborators

3 joint publications

Dipti Talaulikar

3 joint publications

Matthew Ku

3 joint publications

Eliza A Hawkes

2 joint publications

Mary Ann Anderson